Pharmacists are advised to be aware of recommendations made regarding the use of non-steroidal anti-inflammatory drugs (NSAIDs) in children infected with varicella-zoster virus (chickenpox). The [...]
Public Health England (PHE) has reported a continued increase in cases of scarlet fever across England, with 1,319 new cases between 21st to 27th March, the highest weekly total recorded in [...]
Sanofi Pasteur MSD announced that the European Commission has approved a two-dose schedule for adolescent girls and boys aged 9 to 14 for GARDASIL®9, its 9-valent Human Papillomavirus (HPV) [...]
Millions of pounds have been invested in a drug development programme to help boys with a rare life-limiting disease. The John Walton Muscular Dystrophy Research Centre at Newcastle University [...]
During a visit of Professor Dr Her Royal Highness Princess Chulabhorn Mahidol from Thailand to the UCL School of Pharmacy, research achievement and graduate training needs in the area of natural [...]
A new drug to treat Morquio Syndrome, a rare life-limiting inherited disease, will be available on the Welsh NHS, Health and Social Services Minister Mark Drakeford has announced. The Minister [...]
As a member of the Rare Disease Forum, the Association of the British Pharmaceutical Industry (ABPI) has welcomed the latest report and its recognition of the role the pharmaceutical industry [...]
Television presenter – and former Rector of the University of Dundee – Lorraine Kelly has become the 100,000th volunteer to join a Scotland-wide effort to help shape the medicines of the future. [...]
Elsevier, a provider of scientific, technical and medical information products and services, has announced that it’s working with Findacure to identify drug repurposing candidates for the rare [...]
Eisai and Charles River Laboratories have announced that they have signed a collaboration agreement which will see Charles River scientists work at Eisai’s research and development [...]
